Sage ERP I White Paper
|
|
- Suzan Bradford
- 8 years ago
- Views:
Transcription
1 The Premier Provider of Effective Business Software Solutions National Presence, Local Touch BLYTHE I White Paper Proactive Regulatory Compliance for Biopharmaceutical Global Competitiveness Prepared exclusively for Sage by Cambashi, Inc.
2 Table of Contents The Mad Dash to Capture Emerging Market Opportunities... 3 A New Landscape for Regulatory Compliance... 4 Leveraging Regulatory Compliance for Global Competitiveness... 6 Proactive Compliance... 7 Cambashi Inc. Proactive Regulatory Compliance for Biopharmaceutical Global Competitiveness paper #U2995g. This publication is protected by United States copyright laws and international treaties, and is copyrighted by Cambashi Inc. This document may not be reproduced, distributed, or posted on a website by anyone except the sponsor Sage Software, Inc. without prior written consent of Cambashi Inc. Unauthorized reproduction of this publication or any portion of it may result in severe civil and criminal penalties, and will be prosecuted to the maximum extent necessary to protect the rights of the publisher. The information in this report is from a wide variety of sources that represent the best information available to Cambashi Inc. This report includes our interpretation of information in the public domain or released by responsible officers in relevant organisations. Some information is from sources we cannot verify. We survey judgment samples, and results are not statistically significant unless so stated. Cambashi Inc. cannot guarantee that the report is accurate or complete. Information changes with time. The analysis, opinions, and estimates in this report reflect our judgments as of writing but are subject to change without notice. Cambashi Inc. shall not be liable for any loss or injury resulting from use of this information. All trademarks are the property of their respective owners. Cambashi Inc. may have a consulting relationship with a company being reported on. It is not an offer to sell or a solicitation of an offer to buy any securities. Cambashi Inc., its staff, their families, and associates may or may not have a position in or with respect to any securities mentioned herein. Proactive Regulatory Compliance for Biopharmaceutical Global Competitiveness 2
3 The Premier Provider of Effective Business Software Solutions National Presence, Local Touch BLYTHE The Mad Dash to Capture Emerging Market Opportunities The writing is on the wall for the biotechnology and pharmaceutical industry: New markets matter. As blockbuster patents expire in the next five years, there are not enough new products in the pipeline to make up for those lost revenues. This could cripple the industry were it not for the emerging growth regions outside the developed U.S., European, and Japanese markets, where most pharmaceutical commercialization has been focused to date. According to IMS Health, developed markets will only grow 3-6% through 2014, while emerging markets will grow about 14-17%, as shown in Figure 1. China alone, which is the largest growth market, is expected to see pharmaceutical sales increases of 20% or more on an annual basis. Sales in India are also growing rapidly at about 16%, which is fueled by generics. There are 17 emerging markets (see Figure 2) that offer enormous opportunities. Their populations are aging and require therapeutic treatments, and their middle class increasingly has disposable income to purchase treatments not covered by their healthcare system. As enticing as the opportunities are, few pharmaceutical companies have a solid foothold in these markets. IMS estimates that even the top 15 companies by revenue collectively get no more than 10 percent of their sales from these growth regions. Abbott, Eli Lilly, GlaxoSmithKline (GSK), Merck, Novartis, Pfizer, and Sanofi-Aventis have begun to acquire local companies, develop local alliances, or invest in local R&D. Yet the industry has been slow to recognize the opportunity. If they don t act fast, as IMS has strongly urged, even the world biopharm leaders will lose out to local companies with established brands that are eager to benefit from their regions changing economies. This urgency is driving a flurry of new deals in many of the 17 regions highlighted by IMS. Proactive Regulatory Compliance for Biopharmaceutical Global Competitiveness 3
4 There are also challenges to global expansion, which companies need to take into consideration. o Compliance complexity: Each country has its own regulatory bodies and requirements. o Competitors: Each emerging country has its own domestic brands, and knowing how to differentiate and price against those is critical. o New cultures: How pharmaceuticals are sold and marketed, packaging preferences, where they are dispensed, and how companies are reimbursed may vary by country. o Pricing and margin pressure: Healthcare in many of these regions is run by the government or nonprofit institutions that will not pay the pricing premiums now attained in the U.S. or even in Europe. Lower prices mean lower margins, and that doesn t account for the high costs of brand promotion and marketing that will be required for a new market. Large players such as GSK report about half their normal margins in these new emerging markets. A New Landscape for Regulatory Compliance Every country has its own regulators and approach to regulating life science companies (see Figure 3). Some are more established than others, and the most established (such as the U.S. s FDA, EU s EMA, and UK s MHRA) frequently issue new guidelines. This is challenging enough when targeting a few countries, and will become far more difficult with each new country added to the base. The International Conference on Harmonization (ICH) is working to create broader standards for R&D and manufacturing regulations to help resolve some of these issues. The ICH is made up of representatives from regulatory agencies, drug companies, and other industry members from multiple countries. Together, they are working toward common regulatory requirements, and the first demonstration of this collaboration is the electronic Common Technical Document (ectd), which a number of companies are now using for submissions in the U.S., Europe, and Japan. Another result is the ICH Q10, which specifies the effective quality system guidelines for the pharmaceutical product lifecycle. Yet harmonization is a long way off from a singular set of regulations. Once harmonized, there will likely always be some differences between the various agency and country regulations. A new state-level law in the U.S. offers a good example. The Product Policy Institute and the National Association of Counties have joined forces to create legislation that puts the Proactive Regulatory Compliance for Biopharmaceutical Global Competitiveness 4
5 responsibility for addressing proper disposal of unwanted medicines by consumers on the producer s shoulders. This would fall outside the FDA and harmonized regulations. So companies must stay up to date and comply with all the requirements in all the countries and locales they target. What is regulated varies. To ensure drug safety, efficacy, and quality, most agencies focus on some version of current good clinical, laboratory, and manufacturing practices (cgcp, cglp, and cgmp). In the U.S., the FDA also oversees promotional advertising, payments made to physicians, patient communication, and off-label drug promotions after product launch. Since 2002, the FDA has updated its cgmp regulations, introduced the Risk Evaluation and Mitigation Strategies (REM) legislation to ensure the right patients are getting the right drugs, and is taking a more active interest in foreign clinical trial oversight. The agency is also starting to put more teeth behind its regulations by stepping up enforcement and increasing its scrutiny of data integrity, unapproved drugs, and global operations (see Figure 4). And it isn t just doing that in the U.S. The FDA now has offices in India and China to inspect plants in these highgrowth regions. Proactive Regulatory Compliance for Biopharmaceutical Global Competitiveness 5
6 The way life science companies have traditionally addressed compliance is by focusing on documentation and only recently in an electronic format. As a result, they have institutionalized compliance practices built upon paper-driven processes, and many of these haven t changed even in departments that now use document management systems. Even in the largest companies, many operations still rely on paper to document their activities. This documentdriven approach to compliance is subject to errors, inefficiencies, and sloppy processes. Paper processes are outdated and expose companies to great risk and unnecessary costs. At a time when enforcement is stronger and companies are going global, more companies are discovering they need to look at compliance differently. Instead of compliance for compliance s sake, the new thinking is that compliance can be the mechanism to document and prove the effectiveness of a streamlined business approach. These companies focus on a business model that can deliver scalable, cost-effective global competitive advantage. Leveraging Regulatory Compliance for Global Competitiveness The new FDA cgmps and ICH Q10 guidelines are well suited to this new thinking. Both of these introduced a systems approach to embedding quality and compliance into good business practices. These will benefit biopharm s bottom and top lines by cutting production, quality, and compliance costs while increasing product reliability, time-to-market, and inventory turns. This should lead to improved margins despite price cutting to compete in emerging markets. Q10 compiles existing country-specific GMP regulations and international standard ISO concepts into a pharmaceutical quality system or framework updating prior Q8 and Q9 guidelines. This framework spans the entire drug or biotech product lifecycle, from development into manufacturing and out to end-of-life discontinuation. The four key elements of the system are shown in Figure 5. It is basically a continuous improvement approach, with monitoring, change management, reviews, and corrective and preventive actions. Q10 relies on: o Knowledge management, which is a systematic approach to acquiring, analyzing, storing and disseminating information related to products, processes, and components 1 across the lifecycle. o Quality risk management, which is used to proactively identify and control the potential for quality risks across the lifecycle. o Key performance indicators to monitor the effectiveness of the system and drive continuous improvement. So being more systematic, proactive, and understanding and improving performance is clearly sound business. Other benefits of implementing Q10 involve breaking down organization silos and facilitating cross-functional communication, a companywide data repository, and management involvement. In April 2009, the FDA sanctioned the use of Q10, encouraging companies to adopt the quality management system for the many elements not covered in the 2002 updated cgmp. Q10 also backs up these revised cgmps, which specifically address the systematic regulation of product quality through Process Analytical Technology (PAT) and Quality by Design (QbD). Proactive Regulatory Compliance for Biopharmaceutical Global Competitiveness 6
7 Proactive Compliance Some companies are moving forward aggressively to improve and take on this proactive approach to compliance as the FDA and ICH Guidelines recommend. In its 2009 study, PharmaManufacturing.com found a growing divide between those companies (large and small) that are adopting the FDA s cgmp guidance for PAT and QbD and those that are lagging behind. About half are adopting PAT and another 20 percent of companies planning a PAT project, while a third have no plans at all. About half are also getting serious about adopting QbD, while the other half has no intentions to address it any time soon. Why should you be in the group that is adopting these? In short, they can improve your business results. Process Analytical Technology for in-process control is a means to lower the cost of quality, reduce product cycle times by speeding release, and reduce the environmental impact of production activities. Quality by Design focuses on increasing quality assurance and reducing risk while allowing an envelope in which production can achieve continuous improvement goals without revalidating. QbD is an efficient and flexible model for producing cost-effective, highly reliable, regulatory-compliant drugs across a global supply chain and product lifecycle. To fully implement PAT, QbD, and Q10, companies need integrated information systems. These systems must provide the ability to access data across the product lifecycle and supply chain and transform that data into knowledge, process optimization, and proactive decision making. Today, the industry is also divided between companies that still operate with a lot of paper and those that are becoming more fully automated and cross-functionally integrated. Information integration is still a great challenge for the vast majority of companies that have data spread across the organization in diverse databases and IT platforms. While no single system can handle all of these needs, the backbone for information integration is usually the business software. Proactive Regulatory Compliance for Biopharmaceutical Global Competitiveness 7
8 The Premier Provider of Effective Business Software Solutions National Presence, Local Touch BLYTHE Enterprise resource planning (ERP) and its affiliated capabilities allow companies to manage the explosion of information that occurs with globalization and to more easily keep up as regulations change. These systems become the system of record for products, materials, suppliers, and customers, plus all of the transactions in inbound and outbound orders. ERP can also plan and manage production and distribution activities. The best systems include business intelligence to analyze where things are going well to replicate that success as well as to pinpoint areas that need attention. This is the foundation of being proactive. Being proactive in the pharmaceutical and biotechnology businesses requires proactive compliance. Historic ways of working were reactive and high risk. Today, the regulatory agencies and organizations working to harmonize global regulations have developed systems that are in the best interest of the public and the industry. Those companies first to adopt their latest guidelines will gain a more efficient, flexible, faster, and cost-effective business model that can give them a competitive advantage in emerging markets. The opportunity today is to leverage the regulations to attain leading-edge business processes and performance rather than see regulations as a requirement for compliance. 1 FDA Guidance for Industry Q8, Q9, and Q10 Questions and Answers; Proactive Regulatory Compliance for Biopharmaceutical Global Competitiveness 8
9 About Sage North America Sage North America is part of The Sage Group plc, a leading global supplier of business management software and services. Sage North America employs 4,000 people and supports 3.1 million small and midsized business customers. The Sage Group plc, formed in 1981, was floated on the London Stock Exchange in 1989 and now employs 13,100 people and supports 6.2 million customers worldwide. For more information, please visit the website at About Cambashi Cambashi, based in Cambridge UK and Cummaquid, MA, USA, provides independent research and analysis on the business benefits of using IT in value-adding industries. Cambashi delivers the latest global market data, plus perspectives on the changing state of technology and current business issues in manufacturing, process, distribution, energy, utilities, and construction industries. Our consulting analysts partner with each client to solve difficult problems, clarify decisions, articulate value, and craft a unique path to market rewards. Proactive Regulatory Compliance for Biopharmaceutical Global Competitiveness 9
10 The information contained in this material represents the views of Sage on the issues discussed herein current as of the date of publication. As market conditions are always subject to change, the information contained herein shall not be interpreted as any commitment from Sage. This material is for informational purposes only and Sage makes no warranties, expressed or implied. Sage Wireless Way Suite 120 Richmond BC V6V 0A3 tel I fax Sage Software, Inc. All rights reserved. Sage, the Sage logos, and the Sage product and service names mentioned herein are registered trademarks or trademarks of Sage Software, Inc., or its affiliated entities. All other trademarks are the property of their respective owners /10
Sage ERP I White Paper
The Premier Provider of Effective Business Software Solutions National Presence, Local Touch 1.800.4.BLYTHE www.blytheco.com I White Paper Profitable Innovation Medical Device Business Model for Growth
More informationSage ERP I White Paper
I White Paper Strategic Partnering in the Speciality Chemicals Industry Prepared exclusively for Sage by Cambashi, Inc. www.cambashi.com Table of Contents A Restructuring that Changes the Chemical Industry...
More informationTotal Product Lifecycle Management: Lowering Costs while Increasing Quality
Axendia Cambashi Inc. 668 Stony Hill Road, Suite # 316 PO Box 463 Yardley, PA 19067 Cummaquid, MA 02637 United States of America United States of America Tel: +1 (215) 262-8037 Tel: +1 (508) 362-3480 www.axendia.com
More informationGSK Vaccines: Easing Compliance with SAP Process Control
2014 SAP AG or an SAP affiliate company. All rights reserved. GSK Vaccines: Easing Compliance with SAP Process Control GlaxoSmithKline Vaccines Industry Life sciences pharmaceuticals Products and Services
More informationProduct Lifecycle Management for the Pharmaceutical Industry
Product Lifecycle Management for the Pharmaceutical Industry An Oracle White Paper Author: Todd Hein, Oracle Life Sciences Key Contributors: i. Arvindh Balakrishnan, Oracle Life Sciences ii. Hardeep Gulati,
More informationBrand Quality with Asian Advantages
Brand Quality with Asian Advantages ScinoPharm Taiwan, Ltd. No.1, Nan-Ke 8th Road, Tainan Science Park, Shan-Hua, Tainan, 74144, Taiwan TEL : 886-6-505-2888 FAX : 886-6-505-2898 Email Contact : mkt@scinopharm.com
More informationProduct Life Cycle Management in Life Sciences Industry
Life Cycle Management in Life Sciences Industry Evolving from siloed to cross-functional management Audit. Tax. Consulting. Corporate Finance. A need for Lifecycle Management Life Sciences companies are
More informationHow To Build A Business Case For An Enterprise Resource Planning (Erp) Project
I White Paper 7 Steps to Building a Business Case for ERP Table of Contents Executive Summary.. 3 The Need to Align ERP Technology with the Business.. 3 Building the Business Case for ERP.. 3 1. Describe
More informationAn Industry White Paper
Driving Continuity and Collaboration from Lab Floor to Plant Floor to Top Floor An Industry White Paper Who is AspenTech? AspenTech is a global company founded in 1981 with more than 1,300 employees in
More informationTHE BIOTECH & PHARMACEUTICAL INDUSTRY
THE BIOTECH & PHARMACEUTICAL INDUSTRY ESSENTIAL CAREERS INFORMATION CALUM LECKIE KATIE BISARO CAREERS CONSULTANTS What we will cover Sector overview Types of role Graduate recruitment trends and issues
More informationTable of contents. Best practices in open source governance. Managing the selection and proliferation of open source software across your enterprise
Best practices in open source governance Managing the selection and proliferation of open source software across your enterprise Table of contents The importance of open source governance... 2 Executive
More informationSage ERP I White Paper
The Premier Provider of Effective Business Software Solutions National Presence, Local Touch 1.800.4.BLYTHE www.blytheco.com Sage ERP I White Paper The Future of Customer Relationship Management Mobile
More informationHow companies leverage quality and quality certifications to achieve competitive advantage
How companies leverage quality and quality certifications to achieve competitive advantage Eize de Boer Systems & Services Certification International Business Development Manager Pharma Supply Chain for
More informationLead the Retail Revolution.
Lead the Retail Revolution. The retail industry is at the center of a dramatic shift in the way consumers shop and interact with their retailers. After hundreds of years of customers going to the store,
More informationThe complexity of today s pharmaceutical
Reprinted from PHARMACEUTICAL ENGINEERING The Official Magazine of ISPE This article presents a holistic approach to pharmaceutical manufacturing based on product and process knowledge that allows companies
More informationProduct Lifecycle Management in the Medical Device Industry. An Oracle White Paper Updated January 2008
Product Lifecycle Management in the Medical Device Industry An Oracle White Paper Updated January 2008 Product Lifecycle Management in the Medical Device Industry PLM technology ensures FDA compliance
More informationDELIVERED WITH LOGIC.
DELIVERED WITH LO. MANAGE YOUR BUSINESS, DRIVE GROWTH, AND ADAPT TO CHANGE Delivered with Logic. ogic. ogic, Inc. is a SAP Business ByDesign master valueadded reseller and solution and implementation partner.
More informationSage ERP I White Paper. An ERP Guide to Driving Efficiency
I White Paper An ERP Guide to Driving Efficiency Table of Contents Executive Summary... 3 Best-in-Class Organizations Look to Enhance Efficiency... 3 How ERP Improves Efficiency... 3 Results... 6 Conclusion...
More informationCA HalvesThe Cost Of Testing IT Controls For Sarbanes-Oxley Compliance With Unified Processes.
TECHNOLOGY BRIEF: REDUCING COST AND COMPLEXITY WITH GLOBAL GOVERNANCE CONTROLS CA HalvesThe Cost Of Testing IT Controls For Sarbanes-Oxley Compliance With Unified Processes. Table of Contents Executive
More informationOracle Buys Phase Forward Expands Oracle s solutions for the life sciences and healthcare industries
Oracle Buys Phase Forward Expands Oracle s solutions for the life sciences and healthcare industries April 16, 2010 Oracle is currently reviewing the existing Phase Forward product roadmap and will be
More informationEngineering for the new pharma reality
NNE Pharmaplan is an international company specialised in pharma engineering. We help pharmaceutical companies bring products to market by providing flexible, compliant and future-proof solutions. We have
More informationManaging Paper at Its Roots: Extending Beyond Document Management to Enterprise Content Compliance
Managing Paper at Its Roots: Extending Beyond Document Management to Enterprise Content Compliance Global Headquarters: 5 Speen Street Framingham, MA 01701 USA P.508.935.4445 F.508.988.7881 www.healthindustry-insights.com
More informationSerious about safety. Seriously strategic about labeling. If you are serious about safety, you have to be seriously strategic about your labels.
Serious about safety. Seriously strategic about labeling. If you are serious about safety, you have to be seriously strategic about your labels. 02 Clintrak knows how: Strategically engineered. Quality
More informationLogistics. Drug Pooling in the Clinical Trial Supply Chain
Drug Pooling in the Clinical Trial Supply Chain Abstract Global clinical trials require efficient and robust supply chain which can bring more transparency and can introduce risk mitigation strategies.
More informationThe Clinical Trials Directive in the EU: Present and Future Elisabethann Wright, Partner Maurits Lugard, Partner. May 2010
The Clinical Trials Directive in the EU: Present and Future Elisabethann Wright, Partner Maurits Lugard, Partner May 2010 Background (1) The Clinical Trials Directive 2001/20/EC The intention of this Directive
More informationHarness the Power of Partnership Everything is possible when you have the right partner.
Technology Success Accelerate Harness the Power of Partnership Everything is possible when you have the right partner. Avnet Technology Solutions, Americas Intelligent Collaboration Disruptive technologies
More informationGAMP5 - a lifecycle management framework for customized bioprocess solutions
GE Healthcare Life Sciences GAMP5 - a lifecycle management framework for customized bioprocess solutions imagination at work GE Healthcare s engineering department, Customized Bioprocess Solutions (CBS),
More informationEXECUTIVE SUMMARY Prepared for: Pharmaceutical Research and Manufacturers of America (PhRMA) Prepared by: Battelle Technology Partnership Practice
EXECUTIVE SUMMARY Prepared for: Pharmaceutical Research and Manufacturers of America (PhRMA) Prepared by: Battelle Technology Partnership Practice Battelle is the world s largest non profit independent
More informationthrough advances in risk-based
Insight brief Quintiles is a market leader with >100 risk-based monitoring studies Quintiles developed solutions that bring as much as 25% cost reduction over traditional trial execution approaches Transform
More informationSage MAS 90 and 200. Extended Enterprise Suite S
Sage MAS 90 and 200 Extended Enterprise Suite S An End-to-End Approach to Business Software At Sage, we ve been supporting businesses like yours with world-class business software for well over a quarter
More informationSoftware License Asset Management (SLAM) Part 1
LANDesk White Paper Software License Asset Management (SLAM) Part 1 Five Steps to Reduce Software License Costs and Ensure Audit Preparedness Contents A Software Audit Looms in Your Future.... 3 Overbuying
More informationRichard T. Clark Chief Executive Officer and President. Executing on Our Strategy
Richard T. Clark Chief Executive Officer and President Executing on Our Strategy Merck s Plan to Win: Preparing for Our Future Success BECOME THE MOST TRUSTED INDUSTRY LEADER IN DELIVERING VALUE TO CUSTOMERS
More informationAmgen GLOBAL CORPORATE COMPLIANCE POLICY
1. Scope Applicable to all Amgen Inc. and subsidiary or affiliated company staff members, consultants, contract workers and temporary staff worldwide ( Covered Persons ). Consultants, contract workers,
More informationBig Data Approaches to Life Sciences
Big Data Approaches to Life Sciences How big data is changing the way life sciences companies operate Overview As the industry embraces innovation, it is constantly faced with the challenge of meeting
More informationBringing Safe and Cost Effective Products to Market
Industry Solutions Life Sciences Engineering, Project Collaboration, Document Control and Facilities Management Solutions across the Life Sciences Value Chain Industry Solutions Life sciences companies
More informationHow To Improve Efficiency With Business Intelligence
I White Paper Table of Contents Executive Summary.. 3 Improving Operational Efficiency With BI Is A High Priority.. 3 Why BI Is Important.. 3 BI Incorporates Multiple Applications.. 4 Data Consolidation
More informationmysap ERP mysap ERP HUMAN CAPITAL MANAGEMENT
mysap ERP mysap ERP HUMAN CAPITAL MANAGEMENT mysap ERP: YOUR INDUSTRY. YOUR BUSINESS. YOUR FUTURE. mysap ERP is the world s most complete solution to support the foundation of your business, enabling adaptive
More informationEmptoris Contract Management Solution for Healthcare Providers
Emptoris Contract Management Solution for Healthcare Providers An Emptoris White Paper Emptoris, an IBM Company www.emptoris.com CMS-HP-4/12 Emptoris Contract Management Solution for Healthcare Providers
More informationRegulatory Expectations of Executive Management
Regulatory Expectations of Executive Management Steven Lynn, MS, CMQ/OE Director Office of Manufacturing and Product Quality Office of Compliance CDER/US FDA PDA ICH Q10 Executive Management Workshop PDA
More informationGuidance for Industry. Q10 Pharmaceutical Quality System
Guidance for Industry Q10 Pharmaceutical Quality System U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER) Center for Biologics Evaluation
More informationIdentification of Medicinal Products (IDMP) What is necessary in order to be compliant in 2016 and beyond?
Identification of Medicinal Products (IDMP) What is necessary in order to be compliant in 2016 and beyond? February 2015 Audit. Tax. Consulting. Corporate Finance. New ISO standards have been developed
More informationCompany Presentation
Company Presentation DISCLAIMER This document contains forward-looking statements on overall economic development as well as on the business, earnings, financial and asset situation of amp biosimilars
More informationSage 100 ERP I White Paper
I White Paper Stay in Control: The benefits of in-house payroll software How in-house payroll systems deliver long-term control and flexibility over the payroll process Table of Contents Introduction...
More informationEllipse The Enterprise Asset Management (EAM) solution for asset intensive industries
Ellipse The Enterprise Asset Management (EAM) solution for asset intensive industries Ellipse is a fully-integrated Enterprise Asset Management (EAM) application suite providing complete visibility and
More informationCopyright 2000-2007, Pricedex Software Inc. All Rights Reserved
The Four Pillars of PIM: A white paper on Product Information Management (PIM) for the Automotive Aftermarket, and the 4 critical categories of process management which comprise a complete and comprehensive
More informationClinical Trial Trends Outline Complexity for Supply Chain. Scott Ohanesian, VP Commercial Operations APAC Email: Scott.Ohanesian@marken.
Clinical Trial Trends Outline Complexity for Supply Chain Scott Ohanesian, VP Commercial Operations APAC Email: Scott.Ohanesian@marken.com 29 May 2013 Biotechnology Sales on the Rise Source: EvaluatePharma
More informationThe Future of Consumer Health Care
The Future of Consumer Health Care Coming Together To Lead The Consumer Health Care Industry 2 Creating a New Business Model in Consumer Health Care 3 Serve More Consumers In More Parts of the World, More
More informationGlobal Sourcing. Conquer the Supply Chain with PLM and Global Sourcing Solutions. Visibility Planning Collaboration Control
ENOVIA Global Sourcing Conquer the Supply Chain with PLM and Global Sourcing Solutions Visibility Planning Collaboration Control Direct materials sourcing (DMS) is seen as not just an important technology
More informationSparta Systems. Proven Enterprise Quality Management Solutions
Sparta Systems Proven Enterprise Quality Management Solutions Sparta Systems global enterprise quality management solutions (EQMS) enable high-value organizations to safely and efficiently deliver products
More informationSoftware Development for Medical Devices
Overcoming the Challenges of Compliance, Quality and Cost An MKS White Paper Introduction Software is fast becoming the differentiator for manufacturers of medical devices. The rewards available from software
More informationTransform Your SAP Applications Landscape to Meet Changing Business Requirements
SAP Brief SAP Landscape Transformation Objectives Transform Your SAP Applications Landscape to Meet Changing Business Requirements Stay ahead of changing markets and technologies Stay ahead of changing
More informationStreamlining clinical trial supply management
Life Sciences Clinical Trial Supply Management Streamlining clinical trial supply management Driving faster, more effective clinical trials In this white paper A critical step of the development chain:
More informationBiosimilar Monoclonal Antibodies in the Pipeline: Major Players and Strategies
Biosimilar Monoclonal Antibodies in the Pipeline: Major Players and Strategies Fern Barkalow, Ph.D, Senior Analyst, Oncology Citeline One of the biggest challenges facing biosimilar drug developers is
More informationSoftware License Asset Management (SLAM) Part III
LANDesk White Paper Software License Asset Management (SLAM) Part III Structuring SLAM to Solve Business Challenges Contents The Third Step in SLAM: Optimizing Your Operations.... 3 Benefiting from Step
More informationPharma working capital performance highly variable
April 2014 Pharma working capital performance highly variable 41 Billion in Excess Working Capital We last completed this survey in 2012. We expected that there would be a broad improvement across the
More informationBlockbuster!!! Content Management in the Pharmaceutical Industry An Overview. Global Pharma Market Shares by Sales (Approx. USD 700 Billion) Global
Content Management in the Pharmaceutical Industry An Overview Blockbuster!!! Avatar USD 2 Billion revenues Lipitor USD 12.5 Billion in 2008 Dr Arun Gangatkar http://in.linkedin.com/in/drarungangatkar drarunj@gmail.com
More informationVendor Assessment: 2014 Top 10 Life Science Software Vendors
VENDOR ASSESSMENT Vendor Assessment: 2014 Top 10 Life Science Software Vendors Eric Newmark Alan S. Louie, Ph.D. IDC HEALTH INSIGHTS OPINION The 2014 top 10 life science software vendor list is made up
More informationENTERPRISE MANAGEMENT AND SUPPORT IN THE AUTOMOTIVE INDUSTRY
ENTERPRISE MANAGEMENT AND SUPPORT IN THE AUTOMOTIVE INDUSTRY The Automotive Industry Businesses in the automotive industry face increasing pressures to improve efficiency, reduce costs, and quickly identify
More informationICH guideline Q10 on pharmaceutical quality system
September 2015 EMA/CHMP/ICH/214732/2007 Committee for Human Medicinal Products Step 5 Transmission to CHMP May 2007 Transmission to interested parties May 2007 Deadline for comments November 2007 Final
More informationOutperform Financial Objectives and Enable Regulatory Compliance
SAP Brief Analytics s from SAP SAP s for Enterprise Performance Management Objectives Outperform Financial Objectives and Enable Regulatory Compliance Drive better decisions and streamline the close-to-disclose
More informationPHARMACEUTICAL QUALITY SYSTEM Q10
INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE ICH HARMONISED TRIPARTITE GUIDELINE PHARMACEUTICAL QUALITY SYSTEM Q10 Current Step
More informationSage ERP Solutions I White Paper
I White Paper Transforming Finance into a Strategic Resource www.sagenorthamerica.com Table of Contents Executive Summary... 3 Benefits of a Strategic Finance Function... 3 What Finance Needs to Become
More informationSage ERP X3 - A Big Business Killer
The challenges of getting bigger just got smaller. Business was getting too complicated. So we simplified it. Not long ago, selling a good product at a fair price was a solid enough business model to
More informationSage ERP Solutions. Ten Signs You Need a New Solution. Have You Outgrown Your Small Business Accounting Software?
Ten Signs You Need a New Solution Have You Outgrown Your Small Business Accounting Software? Are you experiencing growing pains? Make the move before the warning signs become too much to ignore... Maintaining
More informationAn Enterprise Resource Planning Solution (ERP) for Mining Companies Driving Operational Excellence and Sustainable Growth
SAP for Mining Solutions An Enterprise Resource Planning Solution (ERP) for Mining Companies Driving Operational Excellence and Sustainable Growth 2013 SAP AG or an SAP affi iate company. All rights reserved.
More informationProduct Lifecycle Management in the Food and Beverage Industry. An Oracle White Paper Updated February 2008
Product Lifecycle Management in the Food and Beverage Industry An Oracle White Paper Updated February 2008 Product Lifecycle Management in the Food and Beverage Industry EXECUTIVE OVERVIEW Companies in
More informationUser Agreement. Quality. Value. Efficiency.
User Agreement Quality. Value. Efficiency. Welcome to QVuE, the Leaders Network on Quality, Value and Efficiency website sponsored by The Medicines Company. The information provided in this Webinar Series
More informationDriving Down Compliance Costs with EAM
Driving Down Compliance Costs with EAM 01. Multisite EAM / CMMS Multisite asset management software is in growing demand in the Life Sciences industry. Companies are looking to gain a detailed and standardized
More informationORACLE SUPPLY CHAIN AND ORDER MANAGEMENT ANALYTICS
ORACLE SUPPLY CHAIN AND ORDER MANAGEMENT ANALYTICS KEY FEATURES & BENEFITS FOR BUSINESS USERS Provide actionable information to conduct intelligent analysis of orders related to regions, products, periods
More informationImproving sales effectiveness in the quote-to-cash process
IBM Software Industry Solutions Management Improving sales effectiveness in the quote-to-cash process Improving sales effectiveness in the quote-to-cash process Contents 2 Executive summary 2 Effective
More informationThought Leadership White Paper
Thought Leadership White Paper Introduction Contracts form the foundation of all businesses and every business relationship. They define every aspect of a business s activities procurement, sales, marketing,
More informationIdentity Management & Digital Signatures in the BioPharmaceutical Industry John Hendrix; Program Director CTST 2009
Identity Management & Digital Signatures in the BioPharmaceutical Industry John Hendrix; Program Director CTST 2009 2009 SAFE-BioPharma Association Overview Conducting Business in the Electronic World
More informationThe Geography of Markets for Technology: Evidence from Bio- Pharmaceuticals
The Geography of Markets for Technology: Evidence from Bio- Pharmaceuticals Michelle Gittelman Department of Business and Management Rutgers Business School Newark-New Brunswick, New Jersey The pharmaceutical
More informationLifecycle CMC Management: ICH Q12 Progress to date
Lifecycle CMC Management: ICH Q12 Progress to date BWP/QWP/GMDP IWG Industry European workshop 28-29 October 2015 Jean-Louis ROBERT (EU) Graham Cook (EFPIA) Please take note The following slides represent
More informationBusiness Continuity Overcome the Challenges
Business Continuity Overcome the Challenges A briefing paper by Phoenix IT Infrastructure Support Services Inspiring Partnership Contents Introduction 3 The Business Case 4 Cost Effective Solutions 7 Selling
More informationA Portrait of the Enterprise Software User in the Pharmaceutical Industry
A Portrait of the Enterprise Software User in the Pharmaceutical Industry Rahim Kaba - 1/4/2012 4:44:00 PM My article depicting a portrait of the Indian enterprise software user prompted me to develop
More informationAccelerating Time to Market with the Power of Cloud-Based Integration
Accelerating Time to Market with the Power of Cloud-Based Integration Now more than ever before, flat revenue and increased development costs have made time-to-market a crucial factor in profitability
More informationThe biggest challenges of Life Sciences companies today. Comply or Perish: Maintaining 21 CFR Part 11 Compliance
S E P T E M B E R 2 0 1 3 Comply or Perish: The biggest challenges of Life Sciences companies today are maintaining a robust product pipeline and reducing time to market while complying with an increasing
More informationEXPERTISE FOR WHERE YOU RE HEADED
EXPERTISE FOR WHERE YOU RE HEADED CREATING A ROADMAP FOR TOMORROW We offer a complete range of business technology services fueled by proven methodologies, process optimization and best practices. Whether
More informationMerck: Revitalizing Master-Data Management
2013 SAP AG or an SAP affiliate company. All rights reserved. Merck: Revitalizing Master-Data Management Partner Merck KGaA Industry Pharmaceuticals, Chemicals & Life Sciences Products and Services Pharmaceutical
More informationBIOVIA: SCIENTIFIC INNOVATION IN THE AGE OF EXPERIENCE A NEW SCIENTIFIC COLLABORATIVE ENVIRONMENT
BIOVIA: SCIENTIFIC INNOVATION IN THE AGE OF EXPERIENCE A NEW SCIENTIFIC COLLABORATIVE ENVIRONMENT A NOTE FROM MAX BIOVIA CEO Industries needing science to create products and advance innovation require
More informationTransatlantic Trade and Investment Partnership (TTIP): Towards better health outcomes for patients and economic growth
Transatlantic Trade and Investment Partnership (TTIP): Towards better health outcomes for patients and economic growth 1 About EFPIA Þ EFPIA is the voice of the European innovative pharmaceutical industry,
More informationSTERLING COMMERCE WHITE PAPER. Four Keys to Effectively Monitor and Control Secure File Transfer
STERLING COMMERCE WHITE PAPER Four Keys to Effectively Monitor and Control Secure File Transfer 2 As more information is digitized and more business data is considered critical, you re spending far more
More informationORACLE AGILE PLM FOR THE MEDICAL DEVICE INDUSTRY
ORACLE AGILE PLM FOR THE MEDICAL DEVICE INDUSTRY Enterprise PLM is a strategic approach to managing the lifecycle of a product throughout its full value chain: from initial requirements gathering through
More informationInfor CloudSuite Industrial (SyteLine) for Medical Devices
Medical Devices Infor CloudSuite Industrial (SyteLine) for Medical Devices Stay current with the shifting standards of FDA compliance For medical device manufacturers, advancing and maintaining information
More informationAccenture Accelerated R&D Services:
Accenture Life Sciences Rethink Reshape Restructure for better patient outcomes Accenture Accelerated R&D Services: Pharmacovigilance Services Overview At our company, we are focused on improving lives
More informationOPERATIONALIZING EXCELLENCE IN THE GLOBAL REGULATORY SUBMISSIONS PROCESS
OPERATIONALIZING EXCELLENCE IN THE GLOBAL REGULATORY SUBMISSIONS PROCESS INTRODUCTION As life sciences companies face expiring patents and shrinking drug-development pipelines, it s never been more important
More informationSiemens Industry Automation Division
Siemens Division Pharmaceutical and Life Science Industries Key Trends in the Pharmaceutical Industry Regulation Economic pressure Risk based approach More patient protection Anti counterfeit E- submission
More informationSage ERP I White Paper. Optimize Your System: How to Avoid Implementation Sins
I White Paper Optimize Your System: How to Avoid Implementation Sins Introduction Enterprise resource planning (ERP) systems improve the way of doing business. By providing accurate, real-time information
More informationPharmaceutical Distribution Security Alliance (PDSA)
Pharmaceutical Distribution Security Alliance (PDSA) Our Mission The Pharmaceutical Distribution Security Alliance's (PDSA) mission is to develop and help enact a federal policy proposal that enhances
More informationThe Role of the CRO in Effective Risk-Based Monitoring
New Whitepaper The Role of the CRO in Effective Risk-Based Monitoring The clinical trial industry is evolving. In an effort to improve participant safety and data integrity, regulators are encouraging
More informationConnected Product Maturity Model
White Paper Connected Product Maturity Model Achieve Innovation with Connected Capabilities What is M2M-ize? To M2Mize means to optimize business processes using machine data often accomplished by feeding
More informationWe now truly understand what our gross margin is on every job.
Product Overview SAGE SOFTWARE AND SAGE TIMBERLINE OFFICE THE KEYS TO YOUR BUSINESS SUCCESS At Sage Software, one of our guiding principles is customers for life. We understand that the software you choose
More informationTransportation Solutions Built on Oracle Transportation Management. Enterprise Solutions
Transportation Solutions Built on Oracle Transportation Management Enterprise Solutions Optimizing transportation operations and ensuring improved customer service Today s complex and challenging business
More informationThe Amdocs Enterprise Customer Management Solution
The Amdocs Enterprise Customer Management Solution THE MOVE TO ENTERPRISE Most service providers today face profitability challenges and eroding revenue in their consumer business. That s why many operators
More informationFDA Center for Drug Evaluation and Research (CDER)
FDA Center for Drug Evaluation and Research (CDER) Strategic Plan 2013-2017 Table of Contents Section Page I. Introduction.. 3 II. CDER Mission and Basic Business Model.. 3 III. Stakeholder Considerations
More informationNEW CHEMICAL ENTITIES
NEW CHEMICAL ENTITIES PIONEERING PARTNER FOR PEPTIDES With more than 40 years of expertise in peptide synthesis, a track record in process development, large-scale manufacturing and outstanding product
More informationEvolving tactical video production- Creative Studios
WHITEPAPER JUNE 2014 www.beroe-inc.com Evolving tactical video production- Creative Studios Abstract / Business Case 1. Introduction:This whitepaper help pharma clients who allocate lower budgets to their
More informationGlobal Commercial Drug Supply for Trials: How to Achieve Long-term Success Published in Journal for Clinical Studies
How to Achieve Long-term Success Published in Journal for Clinical Studies For more information about sourcing in the US and EU, call +1 610.233.3300 or email sales@myoderm.com Myoderm is a leader in the
More informationMultiple Sclerosis. Current and Future Players. GDHC1009FPR/ Published March 2013
Multiple Sclerosis Current and Future Players GDHC1009FPR/ Published March 2013 Executive Summary Moderate Growth in the Multiple Sclerosis Market is Expected from 2012 2022 GlobalData estimates the 2012
More information